BusinessGE Ventures, Mayo Clinic Ventures and DFJ Invest $13.75M in First Software Platform to Accelerate Cancer Cure Process and DeliveryBy Nasdaq OMXJun 20, 2017, 11:30 AM UTC
BusinessKura Oncology Presents Preliminary Clinical and Preclinical Data for Tipifarnib in the Treatment of Relapsed or Refractory Peripheral T-Cell LymphomaBy Nasdaq OMXJun 14, 2017, 11:30 AM UTC
BusinessElev8 Brands, Inc. Announces Attendance of Coffee Fest Trade Show in Chicago, IL June 9th-June 11th and the Expansion of Private Label BusinessBy Nasdaq OMXJun 8, 2017, 12:30 PM UTC
BusinessKura Oncology Announces Data Presentations for Tipifarnib at the International Conference on Malignant Lymphoma and the European Hematology Association Annual MeetingBy Nasdaq OMXJun 7, 2017, 11:30 AM UTC
BusinessCURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting CannabinoidsBy Nasdaq OMXMay 31, 2017, 1:04 PM UTC
BusinessCURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting CannabinoidsBy Nasdaq OMXMay 31, 2017, 1:04 PM UTC
BusinessCURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting CannabinoidsBy Nasdaq OMXMay 31, 2017, 1:04 PM UTC
